16:36 IST
BSE
Other Announcement
Bacil Pharma Other Announcement
Bacil Pharma Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 30, 2025.
Bacil Pharma Ltd
- Share price
- ₹26.39
- Market cap
- ₹37.88 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 57.8×Sector 47.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Board Meeting Date 5Financial Results 4Fund Raise 3Merger & Restructuring 2Board Meeting Outcome 2Management Change 1Capital Structure Change 1Annual Report 1Annual General Meeting 1
Time
5 announcements with these filters
14:33 IST
BSE
Other Announcement
Bacil Pharma Other Announcement
Bacil Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with regulatory disclosure requirements.
23:38 IST
BSE
Other Announcement
Bacil Pharma Other Announcement
Bacil Pharma Ltd has withdrawn its intimation for appointing two independent directors. This follows a failure to receive necessary consent documents.
10:28 IST
BSE
Other Announcement
Bacil Pharma Other Announcement
Nikita Hiren Patel sold a 2.27% stake in Bacil Pharma Limited via open-market transactions. Her total holding reduced from 19.44% to 17.17% following the disposal.
21:02 IST
BSE
Other Announcement
Bacil Pharma Other Announcement
Bacil Pharma Limited reported zero Related Party Transactions for the half-year ended March 31, 2026. This NIL disclosure maintains regulatory compliance and transparency.